Reto Naef, founder, Chief Executive Officer (CEO) and president of the board of TOPADUR PHARMA AG, holds a Ph.D. in chemistry from the ETH and a MBA from the University of Zürich.
He has 30 years of pharmaceutical leadership experience in managing global groups of up to 450 scientists in research. He is an expert in drug discovery and early development in immunology, allergy, cardiovascular and infectious diseases. He is an author of 16 patents and made key contributions to several drugs on the market. The leadership team and board members had successful careers in several Pharma and start-up companies, contributed to several drugs on the market and are very experienced in Pharma R&D and marketing.
He has 30 years of pharmaceutical leadership experience in managing global groups of up to 450 scientists in research. He is an expert in drug discovery and early development in immunology, allergy, cardiovascular and infectious diseases. He is an author of 16 patents and made key contributions to several drugs on the market. The leadership team and board members had successful careers in several Pharma and start-up companies, contributed to several drugs on the market and are very experienced in Pharma R&D and marketing.
Speaking In
[Available On-Demand]
TOPADUR Pharma AG is a biopharmaceutical start-up company located at the successful Bio-Technopark…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
